Drug Trial Radar · NCT04219826
Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CK-3773274 in Adults With Hypertrophic Cardiomyopathy
Last checked: Nov 19, 2026Latest source record: Feb 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
96
Actual
Start
Jan 10, 2020
Primary completion
Feb 28, 2023
Study completion Feb 28, 2023
Sponsor
- Lead sponsor
- CytokineticsIndustry
- Sponsor type
- Industry
- First posted
- Jan 7, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is being performed to understand the effect of different doses of CK-3773274 on patients with hypertrophic cardiomyopathy (HCM).
Conditions
- Hypertrophic Cardiomyopathy (HCM)
Interventions
CK-3773274 (5 - 15 mg)Drug
CK-3773274 tablets administered orally once daily
CK-3773274 (10 - 30 mg)Drug
CK-3773274 tablets administered orally once daily
Placebo for CK-3773274Drug
Placebo administered orally once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Adverse Events (AEs)Time frame: 14 weeks
- Incidence of Left Ventricular Ejection Fraction (LVEF) < 50%Time frame: 14 weeks
- Incidence of Serious Adverse Events (SAEs)Time frame: 14 weeks
Locations
22 sites in 4 countries. Site status is shown where the registry gives one.
Cedar-Sinai Medical Center
Los Angeles, California
UCSF Medical Center
San Francisco, California
Northwestern University
Evanston, Illinois
Tufts Medical Center
Boston, Massachusetts
Massachusetts General Hospital
Boston, Massachusetts
Brigham and Women's Hospital
Boston, Massachusetts
Michigan Medicine - University of Michigan
Ann Arbor, Michigan
Washington University School of Medicine
St Louis, Missouri
New York University Langone Health Medical Center
New York, New York
Carolinas Medical Center
Charlotte, North Carolina
Duke Cardiology at Southpoint
Durham, North Carolina
Oregon Health and Science University
Portland, Oregon
Hospital of the University of Pennsylvania (University of Pennsylvania School of Medicine)
Philadelphia, Pennsylvania
UMPC Heart and Vascular Institute
Pittsburgh, Pennsylvania
UT Southwestern Medical Center
Dallas, Texas
Houston Methodist Hospital
Houston, Texas
Intermountain Medical Center
Murray, Utah
University of Virginia Health System
Charlottesville, Virginia
Azienda Ospedaliero Universitaria Careggi
Florence, Italy
Erasmus University Medical Center (Erasmus MC)
Rotterdam, Netherlands
Complejo Hospitalario Universitario A Coruña
A Coruña, Spain
Hospital Universitario Puerta de Hierro de Majadahonda
Madrid, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.